Amgen: Biotech Giant's Path to Growth and Recovery
Amgen has navigated headwinds to chart a path toward renewed growth. This analysis breaks down the catalysts, risks, ...
Budgeting is crucial for effective financial planning. Discover the ways it can help you achieve your financial goals more efficiently.
22,426 articlesAmgen has navigated headwinds to chart a path toward renewed growth. This analysis breaks down the catalysts, risks, ...
The market is navigating a phase many haven’t seen in a generation. Mega-cap tech dominates, valuations look stretche...
Oracle isn't done spending on AI, and the move is shaking up how investors view cloud growth and profitability. This ...
Binance unveils a major expansion into U.S. stocks for non-U.S. users, with 7,000+ assets and a plan to tokenize shar...
The U.S. is weighing a policy shift to direct some of Iran's frozen assets toward Gulf allies for reconstruction. Off...
New cost tallies show the true price of the Iran conflict to U.S. taxpayers near $200 billion, far above early Pentag...
In 2026, investors face a choice between a pure digital disruptor in LatAm and a large US consumer lender with a heav...
If Vertex pursues Crinetics, what would it mean for the stock? This article breaks down potential value, risks, and t...
A public feud over college’s worth heats up in 2026 as Peter Thiel backs alternatives with large grants. The former g...
Trump says the conflict is complete, but Wall Street expects the Fed to stay hawkish. Oil spikes, inflation worries, ...
Analysts say cheap power, vast manufacturing, and a surge in open-source AI development could make China the big winn...
As AI bills climb, more firms are turning to cheaper open-source AI models to manage budgets. The trend signals a shi...